Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Daikenchuto (TU-100), a Gastrointestinal Nerve Modulator, on Rectal Sensation in Patients With Irritable Bowel Syndrome

NCT01890837 is registered in ClinicalTrials.gov with Tsumura USA as lead sponsor.

NCT NCT01890837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01890837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Daikenchuto (TU-100), a Gastrointestinal Nerve Modulator, on Rectal Sensation in Patients With Irritable Bowel Syndrome
Lead sponsor
Tsumura USA
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2013
Completion date
March 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, digestive system diseases, gastrointestinal diseases, intestinal diseases, irritable bowel syndrome